 |
|
|
[ send your article ] Articles 04More articles: [newest], [05], [04], [03], [02], [01] There is an increasing belief among at least some opinion-leaders in the prostate cancer treatment community that androgen deprivation therapy (ADT) has been and still is being significantly overused. [ read full article ] One of the conclusion of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden, shows that hormone therapy is often given to patients with advanced prostate cancer. [ read full article ] The Gleason scoring system is an important method of classifying prostate cancers based on the appearance of the prostate cancer cells under a microscope. [ read full article ] Four risk factors that can help predict how long men could survive with metastatic prostate cancer have been identified by researchers from the Duke Comprehensive Cancer Center, who say such information would help doctors individualize treatments. [ read full article ] While prostate specific antigen (PSA) testing has been the standard screening tool for prostate cancer for several decades, results of a study recently published in The New England Journal of Medicine question the effectiveness of PSA screening in reducing death from prostate cancer. [ read full article ] According to a new study from Henry Ford Hospital, for men younger than 50 with prostate cancer, undergoing a radical prostatectomy can greatly increase their chances for long-term survival. [ read full article ] In the oncologic world, there is still a general reluctance to use chemotherapy in the elderly because of concerns regarding increased toxicity and tolerability. [ read full article ] Several recent studies suggest statins help reduce the risk of erectile dysfunction and prevent prostate cancer. All conclusions were to be reported Sunday in Chicago at the American Urological Association's (AUA) annual meeting. [ read full article ] Men diagnosed with prostate cancer in their 40s and 50s are often steered toward surgery (called a radical prostatectomy), since it's thought to offer the best chance for long-term survival. What's more, removing the prostate and examining it in a lab is the only way to know for sure how much cancer was there and how likely it is to return. [ read full article ] Researchers of Memorial Sloan-Kettering Cancer Center, New York, report in the April issue of The Journal of Urology that carefully selected men with "low-risk" prostate cancer can safely delay treatment and opt instead for active surveillance. [ read full article ] In 2005, the Scandinavian Prostate Cancer Group Study 4 (SPCG-4) reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. [ read full article ] A multi-center study of prostate cancer patients appearing in today's Journal of Urology recommends that for some men diagnosed with low-risk prostate cancer, opting not to initially receive treatment can be safe if they are closely monitored. [ read full article ] A recent study has concluded that cancer anxiety independently and robustly predicts earlier androgen deprivation therapy (ADT) initiation in older men with biochemical recurrence. They note, however, that among older patients with prostate cancer, earlier initiation of ADT may have limited impact on life expectancy and can negatively impact patients’ health-related quality of life. [ read full article ] Studies have revealed that prostate cancer grows when exposed to the male hormone testosterone and its related hormones, called androgens. For this reason, hormone treatment is given to halt the production of testosterone and androgens. [ read full article ] A recent article by Collins on the CalorieLab web site offers a sound summary of “where we are” with regard to the use of supplements in the prevention of prostate cancer. [ read full article ] A new robotic surgical technique developed at The Cancer Institute of New Jersey (CINJ) for the removal of all or part of the prostate gland is showing what investigators call a “dramatic improvement” in a male’s sexual potency rate. [ read full article ] Prostate cancer has an excellent survival rate, therefore it must not cause neglect of other illness. A group of researchers at the University of Texas Medical Branch, Galveston, reports in the Journal of the American Geriatric Society that the majority of male population with early-stage, low- or moderate-grade prostate cancer die from causes other than prostate cancer. [ read full article ] Although primary prostate surgery or radiotherapy is successful in many cases of prostate cancer, some patients will suffer a recurrence of the disease, which is most often first detected by a measurable PSA blood test. This so-called biochemical recurrence affects 30% to 40% of patients after surgery. [ read full article ] Although primary prostate surgery or radiotherapy is successful in many cases of prostate cancer, some patients will suffer a recurrence of the disease, which is most often first detected by a measurable PSA blood test. This so-called biochemical recurrence affects 30% to 40% of patients after surgery. [ read full article ] In the past year or so there have been three significant technological advances in the use of external beam radiotherapy for the treatment of localized prostate cancer. It is about CyberKnife Radiotherapy, RapidArc Radiotherapy and Calypso system. [ read full article ] More articles: [newest], [05], [04], [03], [02], [01] [ send your article ] NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment. |
|